Search by Drug Name or NDC

NDC 75834-0323-02 Calcium Acetate 667 mg/1 Details

Calcium Acetate 667 mg/1

Calcium Acetate is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Nivagen Pharmaceuticals, Inc.. The primary component is CALCIUM ACETATE.

MedlinePlus Drug Summary

Calcium acetate is used to control high blood levels of phosphorus in people with kidney disease who are on dialysis (medical treatment to clean the blood when the kidneys are not working properly). Calcium acetate is in a class of medications called phosphate binders. It binds phosphorus that you get from foods in your diet and prevents it from being absorbed into your blood stream.

Related Packages: 75834-0323-02
Last Updated: 05/26/2024
MedLinePlus Full Drug Details: Calcium Acetate

Product Information

NDC	75834-0323
Product ID	75834-323_da6dc42d-1ae6-45ff-8a81-20a7135f8d17
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Calcium Acetate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Calcium Acetate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	667
Active Ingredient Units	mg/1
Substance Name	CALCIUM ACETATE
Labeler Name	Nivagen Pharmaceuticals, Inc.
Pharmaceutical Class	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA217205
Listing Certified Through	2024-12-31

Package

NDC 75834-0323-02 (75834032302)

Pricing Information	N/A
NDC Package Code	75834-323-02
Billing NDC	75834032302
Package	200 CAPSULE in 1 BOTTLE (75834-323-02)
Marketing Start Date	2023-12-07
NDC Exclude Flag	N